Definition: In this task, you are given text for US Congressional and California state bills, your task is to generate a summary for this bill.
Input: SECTION 1. SHORT TITLE.

This Act may be cited as the ''Compassionate Access, Research
Expansion, and Respect States Act of 2017'' or the ''CARERS Act of
2017''.

SEC. 2. FEDERALISM IN DRUG POLICY.

Section 708 of the Controlled Substances Act (21 U.S.C. 903) is
amended--
(1) by striking ''No provision'' and inserting the
following:
''(a) In General.--Except as provided in subsection (b), no
provision''; and
(2) by adding at the end the following:
''(b) Compliance With State Law.--Notwithstanding any other
provision of law, the provisions of this title relating to marihuana
shall not apply to any person acting in compliance with State law, as
determined by the State, relating to the production, possession,
distribution, dispensation, administration, laboratory testing,
recommending use, or delivery of medical marihuana.''.

SEC. 3. EXCLUSION OF CANNABIDIOL FROM DEFINITION OF MARIHUANA.

Section 102 of the Controlled Substances Act (21 U.S.C. 802) is
amended--
(1) in paragraph (16)--
(A) by striking ''or cake, or the sterilized'' and
inserting ''cake, the sterilized''; and
(B) by adding '', or cannabidiol'' before the
period at the end; and
(2) by adding at the end the following:
''(57) The term 'cannabidiol' means the substance
cannabidiol, as derived from marihuana or the synthetic
formulation, that contains not greater than 0.3 percent delta-
9-tetrahydrocannabinol on a dry weight basis.''.

SEC. 4. CANNABIDIOL DETERMINATION BY STATES.

Section 201 of the Controlled Substances Act (21 U.S.C. 811) is
amended by adding at the end the following:
''(k) Cannabidiol Determination.--If a person grows or processes
marihuana for purposes of making cannabidiol in accordance with State
law, the marihuana shall be deemed to meet the concentration limitation
under section 102(57), unless the Attorney General determines that the
State law is not reasonably calculated to comply with section
102(57).''.

SEC. 5. RESEARCH.

(a) In General.--Not later than 180 days after the date of
enactment of this Act, the Secretary of Health and Human Services shall
terminate the Public Health Service interdisciplinary review process
described in the guidance entitled ''Guidance on Procedures for the
Provision of Marijuana for Medical Research'' (issued on May 21, 1999).
(b) Licenses for Marijuana Research.--Not later than 1 year after
the date of enactment of this Act, the Attorney General, acting through
the Drug Enforcement Administration, shall issue not less than 3
licenses under section 303 of the Controlled Substances Act (21 U.S.C.
823) to manufacture and distribute marijuana and marijuana-derivatives
for research approved by the Food and Drug Administration.
(c) Marijuana Research.--
(1) In general.--Section 303(f) of the Controlled
Substances Act (21 U.S.C. 823(f)) is amended--
(A) by redesignating paragraphs (1) through (5) as
subparagraphs (A) through (E), respectively;
(B) by striking ''(f) The Attorney General'' and
inserting ''(f)(1) The Attorney General'';
(C) by striking ''Registration applications'' and
inserting the following:
''(2) Registration applications'';
(D) in paragraph (2), as so designated, by striking
''schedule I'' each place that term appears and
inserting ''schedule I, except marijuana,'';
(E) by striking ''Article 7'' and inserting the
following:
''(4) Article 7''; and
(F) by inserting before paragraph (4), as so
designated, the following:
''(3)(A) Not later than 180 days after the date of enactment of
this paragraph, the Secretary shall promulgate regulations that require
the Secretary to register a practitioner to conduct research on
marihuana if--
''(i) the applicant is authorized to dispense, or conduct
research with respect to, controlled substances in schedules
II, III, IV, and V under the laws of the State in which the
applicant practices; and
''(ii) the applicant's research protocol--
''(I) has been reviewed and allowed by--
''(aa) the Secretary under section 505(i)
of the Federal Food, Drug, and Cosmetic Act (21
U.S.C. 355(i)); or
''(bb) the National Institutes of Health or
another Federal agency that funds scientific
research; or
''(II) in the case of nonhuman research that is not
federally funded, has been voluntarily submitted by the
applicant to, and approved by, the National Institutes
of Health.
''(B) The Secretary shall grant an application for registration
under this paragraph unless the Secretary determines that the issuance
of the registration would be inconsistent with the public interest. In
determining the public interest, the Secretary shall consider the
following factors:
''(i) The applicant's experience in dispensing, or
conducting research with respect to, controlled substances.
''(ii) Compliance with applicable Federal or State laws
relating to controlled substances.
''(iii) Conduct by the applicant that may threaten the
public health and safety.''.
(2) Conforming amendment.--Section 102(16) of the
Controlled Substances Act (21 U.S.C. 802(16)) is amended by
inserting ''or 'marijuana''' after ''The term 'marihuana'''.

SEC. 6. PROVISION BY DEPARTMENT OF VETERANS AFFAIRS HEALTH CARE
PROVIDERS OF RECOMMENDATIONS AND OPINIONS REGARDING
VETERAN PARTICIPATION IN STATE MARIJUANA PROGRAMS.

Notwithstanding any other provision of law, the Secretary of
Veterans Affairs shall authorize physicians and other health care
providers employed by the Department of Veterans Affairs to--
(1) provide recommendations and opinions to veterans who
are residents of States with State marijuana programs regarding
the participation of veterans in such State marijuana programs;
and
(2) complete forms reflecting such recommendations and
opinions.
Output:
Compassionate Access, Research Expansion, and Respect States Act of 2017 or the CARERS Act of 2017 This bill amends the Controlled Substances Act to provide that the Act's regulatory controls and administrative, civil, and criminal penalties do not apply to a person who produces, possesses, distributes, dispenses, administers, tests, recommends, or delivers medical marijuana in compliance with state law. The bill also: excludes "cannabidiol" (CBD) from the definition of "marijuana"; limits the concentration of delta-9-tetrahydrocannabinol (THC) in CBD to 0.3 percent on a dry weight basis; and deems marijuana grown or processed to make CBD, in accordance with state law, to comply with the THC concentration limit unless the Drug Enforcement Administration (DEA) determines state law to be unreasonable. The bill directs the Department of Health and Human Services (HHS) to terminate the Public Health Service's interdisciplinary review process that is used to evaluate applications for medical marijuana research. The DEA must license manufacturers and distributors of marijuana for medical research; HHS must register practitioners to conduct research; and the Department of Veterans Affairs (VA) must authorize VA health care providers to provide recommendations and opinions to veterans regarding participation in their states' marijuana programs.